Neogen (NEOG) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -17.18% |
| Nov 30, 2025 | -17.91% |
| Aug 31, 2025 | -52.34% |
| May 31, 2025 | 60.42% |
| Feb 28, 2025 | -16.17% |
| Nov 30, 2024 | -93.37% |
| Aug 31, 2024 | -32.63% |
| May 31, 2024 | -35.67% |
| Feb 29, 2024 | -3.86% |
| Nov 30, 2023 | -4.54% |
| Aug 31, 2023 | 3.03% |
| May 31, 2023 | 3.36% |
| Feb 28, 2023 | -0.29% |
| Nov 30, 2022 | -19.39% |
| Aug 31, 2022 | -18.07% |
| May 31, 2022 | -1.05% |
| Feb 28, 2022 | -14.97% |
| Nov 30, 2021 | -5.85% |
| Aug 31, 2021 | 8.08% |
| May 31, 2021 | 24.15% |
| Feb 28, 2021 | 6.99% |
| Nov 30, 2020 | 5.66% |
| Aug 31, 2020 | -16.34% |
| May 31, 2020 | 24.44% |
| Feb 29, 2020 | 1.41% |
| Nov 30, 2019 | 7.22% |
| Aug 31, 2019 | 3.89% |
| May 31, 2019 | 11.25% |
| Feb 28, 2019 | 7.30% |
| Nov 30, 2018 | 13.50% |
| Aug 31, 2018 | 5.82% |
| May 31, 2018 | 14.17% |
| Feb 28, 2018 | 10.48% |
| Nov 30, 2017 | 11.43% |
| Aug 31, 2017 | 9.72% |
| May 31, 2017 | 16.92% |
| Feb 28, 2017 | 13.71% |
| Nov 30, 2016 | 15.66% |
| Aug 31, 2016 | 9.53% |
| May 31, 2016 | -7.31% |
| Feb 29, 2016 | 6.89% |
| Nov 30, 2015 | 8.70% |
| Aug 31, 2015 | 9.19% |